Abstract
The increase in importance of the biopharmaceutical market generates enormous needs in production of therapeutic molecules. The world capacities of production, mainly therapeutic proteins, impossible to obtain by chemical synthesis, are at present insufficient. Besides the economic aspects in set, play, the question of the technologies used to produce these molecules is important: the tried(felt) technologies (bacteria, yeasts, cells of mammals), used for a long time rather widely remain expensive, or see their limited field of application; the innovative technologies (avian cells, animal and plant transgenic, among others), as for them, again have to show their ability.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
